BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15981701)

  • 1. Localised plasma-cell type Castleman's disease and AA-amyloidosis cured by resection. A case report and review of the literature.
    Verbrugghe W; Maes BD; Knockaert DC
    Acta Clin Belg; 2005; 60(1):22-7. PubMed ID: 15981701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman's disease.
    Mandreoli M; Casanova S; Vianelli N; Pasquali S; Zucchelli P
    Nephron; 2002 Mar; 90(3):336-40. PubMed ID: 11867955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare association of Castleman's disease and nephrotic syndrome.
    Tazi I; Rachid M; Quessar A; Benchekroun S
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):116-9. PubMed ID: 21196625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.
    Derici U; Arinsoy T; Ataoglu O; Bali M; Eroglu A; Goker B; Sindel S
    Ann Hematol; 2002 Jul; 81(7):399-401. PubMed ID: 12185513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 21-year-old male patient with nephrotic syndrome and "idiopathic" AA amyloidosis].
    Saura IM; Carretón A; López Guillén E; Alegría MS; Jimeno García L; Ferri B
    Nefrologia; 2004; 24 Suppl 3():109-12. PubMed ID: 15219083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary amyloidosis in Castleman's disease: review of the literature and report of a case.
    Altiparmak MR; Pamuk GE; Pamuk ON; Doğusoy G
    Ann Hematol; 2002 Jun; 81(6):336-9. PubMed ID: 12107565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.
    Yamagata N; Fujio J; Hirai R; Matsumaru M; Tanimura S; Inokuchi C; Shikai T; Takezako N; Nasu M; Sakata Y; Sata N; Nagai H; Saito K; Miwa A
    Int J Hematol; 2006 Jul; 84(1):70-3. PubMed ID: 16867906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis.
    Sugimoto T; Ito J; Takeda N; Gasyu I; Okazaki T; Sakaguchi M; Osawa N; Tanaka Y; Oka K; Uzu T; Kashiwagi A
    Am J Med Sci; 2008 Jun; 335(6):495-8. PubMed ID: 18552583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated intrapulmonary Castleman's disease: a case report, review of the literature.
    Nadir A; Colak N; Koktener A; Yildirim U
    Ann Thorac Cardiovasc Surg; 2014; 20 Suppl():689-91. PubMed ID: 24747548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical unicentric Castleman's disease in children.
    Bouguila J; Lahmer I; Abdelkefi M; Affissath A; Trimeche M; Boughammoura L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Sep; 130(4):221-3. PubMed ID: 23474027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman's disease.
    Shimojima Y; Takei Y; Tazawa K; Gono T; Fushimi T; Matsuda M; Hoshii Y; Ikeda S
    Amyloid; 2006 Sep; 13(3):184-6. PubMed ID: 17062386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotic Syndrome Caused by AA Amyloidosis Secondary to Unicentric Castleman's Disease:Report of One Case].
    You RL; Wen YB; Wang J; Ma J; Chen LM; Li XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):540-544. PubMed ID: 35791957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized Castleman's disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal.
    Androulaki A; Giaslakiotis K; Giakoumi X; Aessopos A; Lazaris AC
    Ann Hematol; 2007 Jan; 86(1):55-7. PubMed ID: 17001479
    [No Abstract]   [Full Text] [Related]  

  • 15. Castleman's disease. A rare cause of isolated retroperitoneal mass.
    Carmona Campos EC; Moreno Arcas P; Hernandez Alcaraz D; Castro Leon A
    Arch Esp Urol; 2014 Mar; 67(2):199-203. PubMed ID: 24691043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castleman's disease of the urachus.
    Rudloff U; Jacobson A; Morgenstern N; Chen Y; Lee BR
    Urology; 2004 Aug; 64(2):376-9. PubMed ID: 15302502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome.
    Paydas S; Paydas S; Ergin M
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):992-5. PubMed ID: 26354576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parapharengeal unicentric Castleman disease with nephrotic syndrome.
    Saghafi H; Aghaali M; Haghighi S
    Iran J Kidney Dis; 2013 Jul; 7(4):316-8. PubMed ID: 23880810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature.
    O'Reilly PE; Joshi VV; Holbrook CT; Weisenburger DD
    Mod Pathol; 1993 Nov; 6(6):776-80. PubMed ID: 8302822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature.
    Menenakos C; Braumann C; Hartmann J; Jacobi CA
    World J Surg Oncol; 2007 Apr; 5():45. PubMed ID: 17466075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.